The synthesis and oral bioavailability of two potential prodrugs of Ganciclovir (1) based on the “trimethyl lock” is described. The mono-3-(2′-Acetoxy-4′ 6′-dimethylphenyl)-3, 3- dimethylpropanoic ester (2) showed a four-fold increase in oral bioavailability over the parent drug in rats.